http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30170942

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 650
issn 0284-186X
1651-226X
issueIdentifier 6
pageRange 644-650
publicationName Acta oncologica (Stockholm, Sweden)
startingPage 644
bibliographicCitation Ullén A, Lennartsson L, Harmenberg U, Hjelm-Eriksson M, Kälkner KM, Lennernäs B, Nilsson S. Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid. Acta Oncol. 2005;44(6):644–50. doi: 10.1080/02841860510029617. PMID: 16165924.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_238d994eb1cbde6d6dac38feeefab130
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7934740f6a75d3cda7c1366231723b64
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3229fcde2370899921b8266245e58e72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbf84f6093c5c796fc13370b63fd91e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0b1290be1aaf78e352e0d3abc7db679
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cad87fe95dfea047e5c73ac89c39b77f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e159c2ebaab2e096045c89ab61c98e81
date 200501
identifier https://doi.org/10.1080/02841860510029617
https://pubmed.ncbi.nlm.nih.gov/16165924
isPartOf https://portal.issn.org/resource/ISSN/0284-186X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1637
https://portal.issn.org/resource/ISSN/1651-226X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid
discusses http://id.nlm.nih.gov/mesh/M0234600
http://id.nlm.nih.gov/mesh/M0006519
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0443608
http://id.nlm.nih.gov/mesh/M0472480
http://id.nlm.nih.gov/mesh/M0184558
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D050071Q000008
http://id.nlm.nih.gov/mesh/D007093Q000008
http://id.nlm.nih.gov/mesh/D011471Q000188
http://id.nlm.nih.gov/mesh/D004164Q000008
http://id.nlm.nih.gov/mesh/D043823Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000494
http://id.nlm.nih.gov/mesh/D050071Q000494
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D007093Q000494
http://id.nlm.nih.gov/mesh/D000077211
http://id.nlm.nih.gov/mesh/D008938Q000187
http://id.nlm.nih.gov/mesh/D001859Q000556
http://id.nlm.nih.gov/mesh/D000077143
http://id.nlm.nih.gov/mesh/D004164Q000494
http://id.nlm.nih.gov/mesh/D043823Q000494
http://id.nlm.nih.gov/mesh/D001859Q000517
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D004357
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 65.